Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Purchases 7,500 Shares

Rezolute, Inc. (NASDAQ:RZLTGet Free Report) insider Brian Kenneth Roberts acquired 7,500 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The stock was bought at an average price of $2.69 per share, for a total transaction of $20,175.00. Following the completion of the acquisition, the insider now owns 50,052 shares in the company, valued at approximately $134,639.88. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Brian Kenneth Roberts also recently made the following trade(s):

  • On Thursday, March 28th, Brian Kenneth Roberts acquired 500 shares of Rezolute stock. The stock was bought at an average price of $2.55 per share, for a total transaction of $1,275.00.
  • On Thursday, March 14th, Brian Kenneth Roberts acquired 10,000 shares of Rezolute stock. The stock was bought at an average price of $1.88 per share, for a total transaction of $18,800.00.
  • On Thursday, March 7th, Brian Kenneth Roberts acquired 500 shares of Rezolute stock. The stock was bought at an average price of $1.85 per share, for a total transaction of $925.00.

Rezolute Stock Up 0.5 %

Shares of NASDAQ RZLT opened at $4.15 on Friday. The stock has a market capitalization of $166.54 million, a price-to-earnings ratio of -3.64 and a beta of 1.29. Rezolute, Inc. has a 52 week low of $0.72 and a 52 week high of $4.40. The firm has a 50-day moving average price of $2.85 and a 200 day moving average price of $1.74.

Institutional Investors Weigh In On Rezolute

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in shares of Rezolute during the first quarter worth about $37,000. Acadian Asset Management LLC purchased a new stake in shares of Rezolute during the first quarter worth about $229,000. Vanguard Group Inc. grew its holdings in shares of Rezolute by 10.4% during the first quarter. Vanguard Group Inc. now owns 1,553,352 shares of the company’s stock worth $3,961,000 after buying an additional 145,700 shares in the last quarter. Rosalind Advisors Inc. purchased a new stake in Rezolute in the first quarter valued at approximately $510,000. Finally, Affinity Asset Advisors LLC purchased a new stake in Rezolute in the first quarter valued at approximately $4,080,000. 82.97% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Maxim Group started coverage on shares of Rezolute in a report on Tuesday, April 9th. They issued a “buy” rating and a $8.00 price objective on the stock. Jonestrading started coverage on shares of Rezolute in a report on Thursday, April 18th. They issued a “buy” rating and a $10.00 price objective on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $14.00 target price on shares of Rezolute in a research report on Wednesday, May 22nd. Finally, JMP Securities reissued a “market outperform” rating and set a $7.00 price objective on shares of Rezolute in a research report on Thursday, April 18th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $8.80.

Read Our Latest Research Report on RZLT

Rezolute Company Profile

(Get Free Report)

Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.

Further Reading

Insider Buying and Selling by Quarter for Rezolute (NASDAQ:RZLT)

Receive News & Ratings for Rezolute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rezolute and related companies with MarketBeat.com's FREE daily email newsletter.